Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
Cash flows from operating activities:
Net loss	$ (71,234)	$ (389,345)
Adjustments to reconcile net loss to net cash used in Operating activities:
Goodwill impairment		299,705
Depreciation and amortization expense	22,458	23,147
Amortization of deferred contract acquisition costs	2,368	1,713
Deferred income taxes		(3,859)
Noncash interest expense	839	838
Stock-based compensation expense	30,004	36,903
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable and unbilled revenue	1,381	193
Accounts payable and accrued expenses	(1,565)	3,623
Deferred contract acquisition costs	(2,082)	(3,730)
Deferred revenue and due to customers	6,707	6,403
Accrued compensation	(14,020)	(8,249)
Other liabilities	(1,000)	(474)
Other assets	(1,181)	(322)
Net cash used in operating activities	(27,325)	(33,454)
Cash flows from investing activities:
Capitalized software development costs	(4,698)	(1,499)
Purchases of property and equipment	(1,965)	(1,405)
Net cash used in investing activities	(6,663)	(2,904)
Cash flows from financing activities:
Proceeds from stock option exercises	3,100	1,178
Proceeds from employee stock purchase plan	1,992	1,788
Payment of contingent consideration for acquisition		(1,828)
Net cash provided by financing activities	5,092	1,138
Net decrease in cash and cash equivalents	(28,896)	(35,220)
Cash and cash equivalents, beginning of period	321,083	365,853
Cash and cash equivalents, end of period	292,187	330,633
Supplemental cash flow information:
Interest paid	820	820
Fixed assets and capitalized software included in accounts payable	99	429
Other receivable related to stock option exercises	4	4
Income taxes paid	$ 303	$ 22